COVID-19 complicated by high Venous Thromboembolism (VTE) and bleed risk in critically ill patients.
Study reports abnormally high VTE and high bleed risk in critically ill COVID-19 patients and calls for more effective prevention strategies.
Clinicians at NHS hospitals are supporting the care of COVID-19 patients with the use of geko™ devices to reduce the risk of blood clots in the most at risk patients.
Firstkind is comprised of a talented and experienced founder, board of directors, and executive management team, all with successful strategic and operational expertise.